Neck Mass Biopsy

Introduction

Neck mass biopsy is a procedure performed to obtain tissue samples from an abnormal mass or swelling identified in the neck. A neck mass can arise from a wide variety of structures within the cervical region, including lymph nodes, salivary glands, thyroid gland, parathyroid glands, vascular structures and soft tissues or its underlying cause spans an equally broad spectrum of pathology ranging from benign reactive conditions to aggressive malignancy. Establishing a definitive tissue diagnosis is essential before any treatment can be planned and image-guided percutaneous biopsy performed by an interventional radiologist provides a precise, safe, and minimally invasive route to obtaining that diagnosis. This procedure has largely replaced open surgical excision biopsy of neck masses in most clinical settings, delivering equivalent diagnostic accuracy with considerably less patient morbidity and a significantly faster pathway to treatment.

Understanding Neck Masses

The neck is an anatomically complex region containing a dense collection of vital structures within a relatively small space. Neck masses may be congenital, inflammatory, infectious or neoplastic in origin. In children, the majority of neck masses are benign and represent reactive lymphadenopathy secondary to upper respiratory tract infection, congenital lesions such as branchial cleft cysts or thyroglossal duct cysts or vascular malformations. In adults, particularly those over the age of forty with a history of tobacco or alcohol use, a new neck mass must be considered malignant until proven otherwise. The most common malignant causes of a neck mass in adults include metastatic squamous cell carcinoma from a primary site in the oral cavity, oropharynx, hypopharynx or larynx, metastatic papillary thyroid carcinoma, lymphoma and less commonly salivary gland malignancy. Infectious causes such as tuberculosis and non-tuberculous mycobacterial infection remain important considerations, particularly in high-prevalence regions and immunocompromised patients. Accurate tissue diagnosis is the essential first step in differentiating between these possibilities and directing appropriate management.

Indications for the Procedure

Neck mass biopsy is indicated whenever a neck mass requires histological or cytological characterization to guide clinical management. Common indications include a persistent neck mass lasting more than two to three weeks without a clear benign cause, a rapidly enlarging neck swelling, a firm or hard neck mass in an adult particularly in association with risk factors for head and neck malignancy, an abnormal neck mass detected incidentally on cross-sectional imaging performed for another purpose, cervical lymphadenopathy with imaging features suspicious for malignancy or lymphoma, a neck mass in a patient with a known primary malignancy where nodal metastasis needs to be confirmed or excluded and suspected tuberculous or atypical mycobacterial lymphadenitis requiring microbiological confirmation. The procedure is also performed to obtain tissue for molecular profiling in patients with metastatic neck disease where identification of the primary tumor site or targetable genetic mutations would influence systemic therapy decisions.

Pre-Procedure Preparation

Before the procedure, the interventional radiologist reviews all available imaging including neck ultrasound, CT with contrast, MRI and PET-CT where applicable, to fully characterize the neck mass, assess its origin, size, internal composition and relationship to adjacent structures, and plan the optimal biopsy approach. The relationship of the mass to the carotid artery, internal jugular vein, external jugular vein, vagus nerve, phrenic nerve, brachial plexus and trachea is carefully assessed to identify the safest needle trajectory. Blood tests including a full blood count and coagulation profile are obtained and anticoagulant medications are reviewed. No fasting is required as the procedure is performed under local anesthetic in most cases. A focused pre-procedure imaging assessment is performed immediately before the biopsy to confirm the current appearance and position of the mass. Informed consent is obtained after a clear explanation of the purpose, technique, expected outcomes, and potential risks of the procedure.

How the Procedure is Performed

The patient is positioned supine on the procedure table with the neck gently extended and the head rotated slightly away from the side of the biopsy to open the surgical field and optimize access to the target mass. The skin overlying the planned entry site is thoroughly cleaned with antiseptic solution and sterile drapes are applied. A real-time imaging assessment of the neck is performed to confirm the position and characteristics of the mass and to finalize the needle trajectory, with particular attention to mapping the course of adjacent vessels using Doppler imaging to ensure the planned needle path is free of vascular structures.

Local anesthetic is administered to the skin and subcutaneous tissues along the intended needle path. A direct, short needle trajectory is selected that provides the most accessible route to the mass while maintaining a safe distance from the carotid artery, jugular vein and other critical neck structures. For solid neck masses, a core biopsy needle is advanced under continuous real-time imaging guidance through the skin and soft tissues of the neck and directly into the target mass. The automated biopsy device is fired to obtain cylindrical tissue cores from representative areas of the lesion. Multiple passes are performed, typically two to four, to ensure sufficient tissue for the complete range of laboratory investigations. For cystic or complex neck masses, aspiration of fluid contents may be performed in addition to or instead of core biopsy, with the aspirated material submitted for cytological analysis and microbiological culture where infection is suspected.

The specific laboratory investigations requested depend on the clinical context. In cases of suspected head and neck squamous cell carcinoma, tissue is submitted for routine histopathology and immunohistochemistry including p16 staining as a surrogate marker for human papillomavirus status, which has important prognostic and therapeutic implications. For suspected lymphoma, cores are submitted for histology, immunohistochemistry, flow cytometry, cytogenetics and molecular studies required for accurate subtype classification. For suspected thyroid malignancy involving cervical nodes, thyroglobulin immunostaining of biopsy material is performed. For infectious causes including tuberculosis, cores are sent for microbiological culture, sensitivity testing and polymerase chain reaction analysis for mycobacterial DNA. Following sample collection, the needle is withdrawn and firm pressure is applied to the puncture site to achieve hemostasis.

Post-Procedure Care and Recovery

Following the biopsy, the patient is observed for thirty to sixty minutes to confirm there are no immediate complications. The majority of patients are discharged home the same day. Mild soreness, bruising or swelling at the puncture site in the neck is expected and resolves within a few days without specific intervention. Patients are advised to avoid strenuous physical activity and heavy lifting for twenty-four hours, keep the puncture site clean and dry and avoid rubbing or pressing on the biopsy site. They are instructed to seek urgent medical attention if they develop a rapidly enlarging neck swelling, difficulty breathing or swallowing, significant pain, numbness or weakness in the arm, or fever, as these symptoms may indicate a hematoma, nerve injury or infective complication requiring prompt assessment. Pathology results are generally available within two to five working days.

Risks and Complications

Neck mass biopsy is a safe procedure with a low overall complication rate in experienced hands. Minor complications include local bruising, small hematoma formation and transient discomfort at the puncture site. Serious complications are uncommon and include significant hemorrhage from injury to the carotid artery or jugular vein, infection, pneumothorax from inadvertent pleural transgression when biopsying low cervical or supraclavicular masses and neurological injury to the vagus or phrenic nerve causing transient or very rarely, persistent symptoms. Real-time imaging guidance with pre-procedure Doppler vascular mapping, meticulous trajectory planning and continuous needle visualization throughout the procedure are the key factors that minimize these risks.

Diagnostic Value and Clinical Impact

The diagnostic accuracy of image-guided core needle biopsy of neck masses is consistently high, with published success rates exceeding ninety percent across a broad range of pathological diagnoses. In head and neck oncology, a definitive tissue diagnosis from a neck mass biopsy allows rapid staging, multidisciplinary treatment planning and prompt initiation of surgery, radiotherapy or systemic therapy. In lymphoma, detailed molecular subtyping from biopsy tissue directly determines the chemotherapy regimen and predicts prognosis. In infectious conditions, microbiological analysis guides targeted antimicrobial therapy. The speed and accuracy with which image-guided neck mass biopsy delivers diagnostic information directly shortens the time from presentation to treatment, which is of critical importance in patients with aggressive malignancy.

Conclusion

Neck mass biopsy performed under real-time imaging guidance is a precise, safe and diagnostically powerful procedure that is fundamental to the evaluation of any patient presenting with a neck mass requiring tissue characterization. By delivering accurate histological, molecular and microbiological information through a minimally invasive percutaneous technique, the interventional radiologist provides the definitive diagnosis that drives all subsequent clinical decision-making. It remains one of the most important and clinically impactful procedures in the interventional radiology practice dedicated to head and neck disease, combining technical precision with outcomes that directly and meaningfully improve patient care.